Spot Trading’s Insmed INSM Stock Holding History

Spot Trading’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-2,297	Closed	-$30K	–	4192
2014 Q3	$30K	Buy	+2,297	New	+$34.6K	﹤0.01%	3884
2014 Q2	–	Sell	-21,125	Closed	-$402K	–	4669
2014 Q1	$402K	Buy	+21,125	New	+$401K	﹤0.01%	2705

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Spot Trading's INSM Position: Q4 2014 in Review

Spot Trading sold out of Insmed (INSM) in Q4 2014, closing a stake of 2,297 shares — an estimated $30K sold.

Spot Trading first reported a position in INSM in Q1 2014 and held it in 2 quarters. The position peaked at $402K in Q1 2014. 96 funds tracked by Wall St. Rank hold INSM as of Q4 2014.

Spot Trading reported no remaining Insmed position as of Q4 2014 after selling out during the quarter.
Spot Trading sold 2,297 Insmed shares in Q4 2014, an estimated $30K.
Spot Trading first reported a position in Insmed in Q1 2014 and held it in 2 quarters.
Spot Trading's Insmed position peaked at $402K in Q1 2014.
96 funds tracked by Wall St. Rank held Insmed as of Q4 2014.

Based on Spot Trading's 13F filing for Q4 2014, filed 13 Feb 2015.